Improving Health-Related Quality of Life in Gastro-Oesophageal Reflux Disease

被引:0
|
作者
Michael J. Shaw
Joseph A. Crawley
机构
[1] Park Nicollet Medical Foundation Health Research Center,
[2] Health Economics and Outcomes Research,undefined
[3] AstraZeneca LP,undefined
来源
Drugs | 2003年 / 63卷
关键词
Omeprazole; Proton Pump Inhibitor; Ranitidine; Esomeprazole; Erosive Oesophagitis;
D O I
暂无
中图分类号
学科分类号
摘要
Gastro-oesophageal reflux disease (GORD) is a common, chronic disorder that can progress to erosive or ulcerative oesophagitis and other complications. Uncomplicated GORD can be defined using criteria that combine symptom assessment and the impact of symptoms on well being or quality of life. The extent of impairment of health-related quality of life (HRQL) in GORD patients has been evaluated using generic HRQL questionnaires, GORD-specific quality of life questionnaires or a combination of the two types of instruments. The impact of GORD on HRQL in affected individuals is proportional to the frequency and severity of heartburn, and is greater than that associated with many other chronic diseases. In the treatment of GORD, the goal should be complete symptom resolution as this has been shown to be associated with a clinically significant improvement in HRQL. Both drug treatment and surgical intervention have been successful in improving HRQL of patients with GORD when complete symptom resolution can be attained
引用
收藏
页码:2307 / 2316
页数:9
相关论文
共 50 条
  • [11] The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of LifeA Literature Review
    Manishi Prasad
    Anne M. Rentz
    Dennis A. Revicki
    PharmacoEconomics, 2003, 21 : 769 - 790
  • [12] Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population - the Kalixanda study
    Ronkainen, J. .
    Aro, P.
    Storskrubb, T.
    Lind, T.
    Bolling-Sternevald, E.
    Junghard, O.
    Talley, N. J. .
    Agreus, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (12) : 1725 - 1733
  • [13] Reduced quality of life in children with Gastro-oesophageal reflux disease
    Marlais, M.
    Fishman, J. R.
    Koeglmeier, J.
    Fell, J. M. E.
    Rawat, D. J.
    ACTA PAEDIATRICA, 2010, 99 (03) : 418 - 421
  • [14] Night-time and daytime atypical manifestations of gastro-oesophageal reflux disease: frequency, severity and impact on health-related quality of life
    Dean, B. B.
    Aguilar, D.
    Johnson, L. F.
    Mcguigan, J. E.
    Orr, W. C.
    Fass, R.
    Yan, N.
    Morgenstern, D.
    Dubois, R. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (04) : 327 - 337
  • [15] Gastro-oesophageal reflux disease
    de Brauw, LM
    Beets, GL
    LANCET, 2000, 356 (9223): : 69 - 70
  • [16] Gastro-oesophageal reflux disease
    Dent, J
    DIGESTION, 1998, 59 (05) : 433 - 445
  • [17] Gastro-oesophageal reflux disease
    Mansberg, Ginni
    JOURNAL OF COMPLEMENTARY MEDICINE, 2007, 6 (01): : 14 - +
  • [18] Gastro-oesophageal reflux disease
    不详
    Nature Reviews Disease Primers, 7 (1)
  • [19] Gastro-oesophageal reflux disease
    Bredenoord, Albert J.
    Pandolfino, John E.
    Smout, Andre J. P. M.
    LANCET, 2013, 381 (9881): : 1933 - 1942
  • [20] Gastro-oesophageal Reflux Disease
    Collard, Jean-Marie
    ACTA ENDOSCOPICA, 2008, 38 (03) : 224 - 224